Stockreport

Biogen Posts Double-Digit Profits, Has Cash to Burn [The Motley Fool]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF Spinal muscular atrophy drug Spinraza makes up for declines in the biotech's multiple sclerosis drug franchise. Drug-developer Biogen ( NASDAQ:BIIB ) repor [Read more]